If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,290.00    -22.00 (-0.95%)
Bid:
2,288.00
Ask:
2,292.00
Spread: 4.00 (0.175%)
Market Cap: £1.52b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Offer Update

2 Nov 2005 10:19

Genus PLC02 November 2005 FOR IMMEDIATE RELEASE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE EXCLUDED TERRITORIES GENUS PLC ___________________________________________________________________________ On 31 October 2005 Bridgewell Securities Limited, on behalf of Genus plc, made arecommended cash offer of 63.2p per Sygen Share for Sygen International plc. Provided below are details of those holders of Sygen Shares who have given toGenus irrevocable undertakings to accept the Offer in respect of their entireinterest in Sygen Shares (other than the Sygen Directors for whom full detailsof their irrevocable undertakings are disclosed in the Offer document posted toSygen Shareholders on 31 October 2005) and also details of those SygenShareholders who have provided to Genus non-binding letters of intent to acceptthe Offer in respect of their entire interest in Sygen Shares. Irrevocable Undertakings Name No. of ordinary shares Percentage of the Existing Sygen Share CapitalFramlington Investment Management 13,268,000 4.5Limited These irrevocable undertakings will cease to be binding in the event a thirdparty announces their intention to make a general offer for all the shares inSygen which values Sygen at 5 per cent. or more higher than the Offer. Letters of Intention Name No. of ordinary shares Percentage of the Existing Sygen Share CapitalPhoenix Asset Management Partners 32,623,345 11.0LimitedINVESCO Asset Management Ltd 27,819,496 9.4 Enquiries Genus Telephone: 01256 347 107Richard Wood / David Timmins Bridgewell Securities Limited Telephone: 020 7003 3000Greg Aldridge / Fred Ward Panmure Gordon (Broking) Limited Telephone: 020 7459 3600Edward Farmer / Mark Lander Certain terms used in this announcement have the same meaning as those used inthe Offer document posted to Sygen Shareholders on 31 October 2005 in relationto the recommended offer by Bridgewell Securities Limited on behalf of Genus plcfor Sygen International Plc. This announcement is issued by Bridgewell Securities Limited, which isauthorised and regulated in the United Kingdom by the Financial ServicesAuthority. Bridgewell Securities Limited is acting exclusively for Genus and noone else in connection with the Offer and will not be responsible to anyoneother than Genus for providing the protections afforded to customers ofBridgewell Securities Limited nor for providing advice in relation to the Offer. Panmure Gordon (Broking) Limited, which is authorised and regulated in theUnited Kingdom by the Financial Services Authority for investment businessactivities, is acting exclusively for Genus and no one else and will not beresponsible to anyone other than Genus for providing the protections afforded tocustomers of Panmure Gordon nor for providing advice in relation to the Offer. The release, publication or distribution of this announcement in jurisdictionsother than the United Kingdom may be restricted by law and therefore persons insuch jurisdictions into which this announcement is released, published ordistributed should inform themselves about, and observe, such restrictions. Anyfailure to comply with the restrictions may constitute a violation of thesecurities laws of any such jurisdiction. The Offer is not being made, directly or indirectly, in or into, or by use ofthe mails of, or by any means or instrumentality (including, without limitation,facsimile transmission, internet, email, telex or telephone) of interstate orforeign commerce of, or any facility of a national state or other securitiesexchange of, the Excluded Territories and subject to certain exceptions cannotbe accepted by any such use, means instrumentality or facility or from theExcluded Territories. Neither the Offer nor the Placing constitutes an offer of securities for sale,or the solicitation of an offer to buy, securities in the United States and thePlacing Shares to be issued pursuant to the Placing have not been and will notbe registered under the United States Securities Act of 1933, or under the lawsof any state, district or other jurisdiction of the Excluded Territories and noregulatory clearances in respect of Placing Shares have been or will be, appliedfor in any jurisdiction. Accordingly, unless an exemption under the USSecurities Act of 1933 or other relevant securities laws is applicable, thePlacing Shares are not being, and may not be offered, sold, resold, delivered ordistributed, directly or indirectly, in or into any of the Excluded Territoriesor to, or for the account or benefit of, any person resident in any of theExcluded Territories. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Feb 20251:30 pmRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSInterim Results
26th Feb 20257:00 amRNSNon-Executive Director Retirement
3rd Feb 20253:17 pmRNSBlock Listing Six Monthly Return
3rd Feb 20259:40 amRNSTotal Voting Rights
15th Jan 20257:00 amRNSHalf Year Trading Update – Ahead of expectations
12th Dec 20245:07 pmRNSNotification of Major Holdings
20th Nov 20243:32 pmRNSResults of AGM
20th Nov 20247:00 amRNSAGM Trading Update
1st Nov 202410:42 amRNSTotal Voting Rights
22nd Oct 20247:00 amRNSChief Financial Officer Retirement
14th Oct 20247:00 amRNSAnnual Report and Annual General Meeting
18th Sep 202411:17 amRNSDirector/PDMR Shareholding
16th Sep 20244:29 pmRNSDirector/PDMR Shareholding
12th Sep 20244:51 pmRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSDirector/PDMR Shareholding
9th Sep 20247:00 amRNSDirector/PDMR Shareholding
6th Sep 202412:31 pmRNSDirector/PDMR Shareholding
6th Sep 202412:30 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSPreliminary Results
1st Aug 20244:26 pmRNSBlock Listing Six Monthly Return
1st Aug 20243:38 pmRNSTotal Voting Rights
17th Jul 20247:00 amRNSTrading Update
3rd Jun 202410:48 amRNSHolding(s) in Company
1st May 20241:59 pmRNSTotal Voting Rights
22nd Feb 20247:00 amRNSInterim Results
15th Feb 20247:00 amRNSTrading Update
1st Feb 20244:24 pmRNSBlock listing Interim Review
1st Feb 20244:21 pmRNSTotal Voting Rights
12th Dec 20237:00 amRNSNon-Executive Director Appointment
22nd Nov 20231:08 pmRNSResult of AGM
22nd Nov 20237:00 amRNSAGM Trading Update
1st Nov 20234:46 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSCapital Markets Event
13th Oct 20237:00 amRNSAnnual Report and Annual General Meeting
5th Oct 202310:19 amRNSPos. determination-PRRS resistant pigs-Colombia
2nd Oct 202311:12 amRNSTotal Voting Rights
15th Sep 20231:07 pmRNSDirector/PDMR Shareholding
15th Sep 202310:04 amRNSDirector/PDMR Shareholding
7th Sep 20237:00 amRNSPreliminary Results
25th Aug 20238:35 amRNSNotification of Major Holdings
23rd Aug 20239:25 amRNSDirectorate Change
1st Aug 202311:41 amRNSBlock listing Interim Review
1st Aug 202311:36 amRNSTotal Voting Rights
3rd Jul 202311:02 amRNSTotal Voting Rights
16th Jun 20235:33 pmRNSNational Milk Records plc - Form 8.3
16th Jun 20235:10 pmRNSForm 8.3 (OPD) - National Milk Records plc
8th Jun 20233:51 pmRNSDirector/PDMR Shareholding
7th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20235:08 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.